HighTower Advisors’s Dermira, Inc. DERM Stock Holding History

HighTower Advisors’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,921	Closed	-$231K	–	2612
2019 Q4	$231K	Buy	14,921 +1,964	+15%	+$17K	﹤0.01%	1876
2019 Q3	$80K	Buy	12,957 +692	+6%	+$5.78K	﹤0.01%	2190
2019 Q2	$117K	Sell	12,265 -4,979	-29%	-$53.6K	﹤0.01%	2145
2019 Q1	$235K	Buy	17,244 +4,181	+32%	+$34.9K	﹤0.01%	1859
2018 Q4	$92K	Buy	+13,063	New	+$143K	﹤0.01%	1970

HighTower Advisors's DERM Position: Q1 2020 in Review

HighTower Advisors sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 14,921 shares — an estimated $231K sold.

HighTower Advisors first reported a position in DERM in Q4 2018 and held it in 5 quarters. The position peaked at $235K in Q1 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

HighTower Advisors reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
HighTower Advisors sold 14,921 Dermira, Inc. shares in Q1 2020, an estimated $231K.
HighTower Advisors first reported a position in Dermira, Inc. in Q4 2018 and held it in 5 quarters.
HighTower Advisors's Dermira, Inc. position peaked at $235K in Q1 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on HighTower Advisors's 13F filing for Q1 2020, filed 21 May 2020.